These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22745327)

  • 1. Promoting long term adherence to antiretroviral treatment.
    Mills EJ; Lester R; Ford N
    BMJ; 2012 Jun; 344():e4173. PubMed ID: 22745327
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term outcome of children receiving antiretroviral treatment in rural South Africa: substantial virologic failure on first-line treatment.
    Barth RE; Tempelman HA; Smelt E; Wensing AM; Hoepelman AI; Geelen SP
    Pediatr Infect Dis J; 2011 Jan; 30(1):52-6. PubMed ID: 20631647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating millions for HIV--the adherence clubs of Khayelitsha.
    Campion EW
    N Engl J Med; 2015 Jan; 372(4):301-3. PubMed ID: 25607424
    [No Abstract]   [Full Text] [Related]  

  • 4. Delivery of antiretroviral therapy in sub-saharan Africa.
    Weller I
    Clin Infect Dis; 2006 Sep; 43(6):777-8. PubMed ID: 16912955
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploring antiretroviral treatment adherence in an urban setting in South Africa.
    Goudge J; Ngoma B
    J Public Health Policy; 2011; 32 Suppl 1():S52-64. PubMed ID: 21730994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Costs and adherence to antiretroviral treatment].
    Ventura-Cerdá JM; Ayago-Flores D; Vicente-Escrig E; Mollá-Cantavella S; Alós-Almiñana M
    Farm Hosp; 2010; 34(6):284-92. PubMed ID: 20692861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The real challenges for scaling up ART in sub-Saharan Africa.
    Van Damme W; Kober K; Laga M
    AIDS; 2006 Mar; 20(5):653-6. PubMed ID: 16514294
    [No Abstract]   [Full Text] [Related]  

  • 8. Applying an expanded social determinant approach to the concept of adherence to treatment: the case of Colombian women living with HIV/AIDS.
    Arrivillaga M; Ross M; Useche B; Springer A; Correa D
    Womens Health Issues; 2011; 21(2):177-83. PubMed ID: 21177122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconsidering the impact of conflict on HIV infection among women in the era of antiretroviral treatment scale-up in sub-Saharan Africa: a gender lens.
    Shannon K; Kaida A; Rachlis B; Lloyd-Smith E; Gray G; Strathdee SA
    AIDS; 2008 Sep; 22(14):1705-7. PubMed ID: 18753938
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of telephonic psycho-social support on adherence to post-exposure prophylaxis (PEP) after rape.
    Abrahams N; Jewkes R; Lombard C; Mathews S; Campbell J; Meel B
    AIDS Care; 2010 Oct; 22(10):1173-81. PubMed ID: 20640949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of adherence to antiretroviral treatment and therapeutic success among children in South Africa.
    Muller AD; Bode S; Myer L; Stahl J; von Steinbuchel N
    AIDS Care; 2011 Feb; 23(2):129-38. PubMed ID: 20645192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "I want to stand on my own legs": A qualitative study of antiretroviral therapy adherence among HIV-positive women in Egypt.
    Badahdah AM; Pedersen DE
    AIDS Care; 2011 Jun; 23(6):700-4. PubMed ID: 21476148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy in low-resource settings.
    Cainelli F; Lanzafame M; Vento S
    Lancet; 2010 Oct; 376(9750):1392. PubMed ID: 20971363
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective, randomized, two-arm controlled study to evaluate two interventions to improve adherence to antiretroviral therapy in Spain.
    Ruiz I; Olry A; López MA; Prada JL; Causse M
    Enferm Infecc Microbiol Clin; 2010; 28(7):409-15. PubMed ID: 20381924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health. Getting HIV treatment to the most people.
    Lynch S; Ford N; van Cutsem G; Bygrave H; Janssens B; Decroo T; Andrieux-Meyer I; Roberts T; Balkan S; Casas E; Ferreyra C; Bemelmans M; Cohn J; Kahn P; Goemaere E
    Science; 2012 Jul; 337(6092):298-300. PubMed ID: 22798404
    [No Abstract]   [Full Text] [Related]  

  • 16. Many in VOICE trial didn't use provided prevention products.
    AIDS Policy Law; 2015 Mar; 30(4):3. PubMed ID: 26094276
    [No Abstract]   [Full Text] [Related]  

  • 17. [More HIV-positive women are referred to a medication adherence clinic than men].
    Schneider MP; Krummenacher I; Bugnon O; Cavassini M
    Rev Med Suisse; 2010 Jul; 6(257):1455-7. PubMed ID: 20806563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV/AIDS in 2004: the epidemiologist's point of view.
    Girardi E; Lauria FN; Ippolito G
    Cell Death Differ; 2005 Aug; 12 Suppl 1():837-44. PubMed ID: 15776000
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictive factors of antiretroviral (ARV) drug adherence among people living with HIV/AIDS attending at Taksin Hospital, Bangkok, Thailand.
    Chamroonsawasdi K; Insri N; Pitikultang S
    J Med Assoc Thai; 2011 Jul; 94(7):775-81. PubMed ID: 21774282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ChatGPT has the potential to enhance antiretroviral therapy adherence among adolescents with HIV in sub-Saharan Africa.
    Kizito S
    Med Educ Online; 2023 Dec; 28(1):2246781. PubMed ID: 37563880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.